Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
JNS > SEC Filings for JNS > Form 8-K on 10-Aug-2012All Recent SEC Filings

Show all filings for JANUS CAPITAL GROUP INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for JANUS CAPITAL GROUP INC


10-Aug-2012

Entry into a Material Definitive Agreement, Unregistered Sale of Equity S


Item 1.01. Entry into a Material Definitive Agreement.

On August 10, 2012, Janus Capital Group Inc. (the "Company") entered into an Investment and Strategic Cooperation Agreement (the "Investment Agreement") with The Dai-ichi Life Insurance Company, Limited (the "Investor"). Pursuant to the terms of the Investment Agreement, the Investor has agreed to use commercially reasonable efforts to acquire, through open market transactions and, at its option, exercise of the options issued pursuant to the Option Agreement (as defined below), at least 15%, and no more than 20%, of the issued and outstanding shares of common stock, par value $0.01 per share, of the Company (the "Company Common Stock") during the period of one year beginning on the date of the Investment Agreement (the "Purchase Window"). The Investor has agreed not to acquire more than 20% of the issued and outstanding shares of the Company Common Stock (the "Ownership Limit") and to reduce its percentage ownership to the Ownership Limit should its percentage ownership exceed the Ownership Limit at any time. In addition, subject to certain conditions, the Investor has committed to invest at least $2,000,000,000 in investment products managed by one or more of the Company's affiliates, at least $300,000,000 of which will be invested within two months of the date of the Investment Agreement. The remaining balance will be invested no later than the end of the fourth full fiscal quarter following the first date on which the Investor owns at least 15% of the issued and outstanding shares of the Company Common Stock (the first date on which the Investor owns at least 15% of the issued and outstanding shares of the Company Common Stock, the "Effective Time").

Board Designation Right. The Board of Directors of the Company (the "Board") has determined that, in accordance with the terms of the Investment Agreement and the procedures and conditions set forth therein, the Investor shall have the right to designate a representative of the Investor for appointment to the Board (the "Investor Representative") until such right is terminated in accordance with the terms of the Investment Agreement. The Investor's right to designate an Investor Representative is exercisable beginning at the Effective Time and may be terminated under certain circumstances set forth in the Investment Agreement.

Standstill Restrictions. The Investor is subject to certain standstill restrictions and cannot, in each case without the Board's consent, among other things, initiate tender or exchange offers for securities of the Company or its subsidiaries, seek the nomination or election of any individual as a director of the Company (other than the Investor's right to designate the Investor Representative as described above), participate in any recapitalization, restructuring, liquidation, dissolution or other similar extraordinary transaction with respect to the Company or its subsidiaries, acquire or obtain any economic interest in securities of the Company (other than the acquisition of up to 20% of the issued and outstanding shares of the Company Common Stock as permitted by the Investment Agreement) or dispose any shares of the Company Common Stock in an unsolicited tender offer (other than under certain circumstances as permitted by the Investment Agreement). The standstill restrictions are suspended if the Investor owns less than 3% of the issued and outstanding shares of the Company Common Stock and, with certain exceptions, terminated upon change of control of the Company.

Transfer Restrictions. The Investor is subject to certain limitations on its ability to transfer its shares of the Company Common Stock and cannot, without the Company's consent, transfer its shares of the Company Common Stock within three years of the date of the Investment Agreement, except that it may transfer its shares of the Company Common Stock to the extent necessary to comply with applicable law, effectively binding written or oral administrative guidance from a governmental authority in Japan or an order by such a governmental authority, upon an insolvency event with respect to either the Company or the Investor, upon an "Event of Financial Distress" (as defined in the Investment Agreement) with respect to the Investor or the Company or upon certain other circumstances set forth in the Investment Agreement. The Company is generally entitled to the right of first offer or the right of first refusal, depending on the nature of the proposed transfer, with respect to the Investor's proposed transfer of its shares of the Company Common Stock.

Preemptive Rights. In the event that the Company proposes to issue new shares of the Company Common Stock, for so long as the Investor owns at least 15% of the issued and outstanding shares of the Company Common Stock, the Investor has the right to purchase up to such number of shares of the Company Common Stock that would allow the Investor to maintain percentage ownership of the issued and outstanding shares of the Company Common Stock that is, after giving effect to the issuance of the new securities, no less than the percentage ownership the Investor had prior to such issuance. The Investor is entitled to exercise its preemptive rights in respect of the Company's issuance of new securities to provide equity compensation for employment for its directors, officers or employees only if such issuance would cause the Investor's percentage ownership to decrease to less than 15% of the issued and outstanding shares of the Company Common Stock. In each case, the Investor does not have preemptive rights to the extent that an issuance of the additional shares of the Company Common Stock to the Investor would require approval of the stockholders of the Company pursuant to Rule 312 of the New York Stock Exchange Listed Company Manual or any successor rule thereof, unless such approval has been obtained.

Registration Rights. At any time following the Effective Time, and without limiting the restrictions on transfers described above, the Investor will be entitled to customary registration rights, including the right to require the Company to file up to two registration


statements to register shares of the Company Common Stock owned by the Investor that were acquired by the exercise of any option under the Option Agreement or pursuant to the Investment Agreement (the "Registrable Shares"), and unlimited prospectus supplements in connection with any take-down from an effective shelf registration statement. In addition, the Investor has certain "piggyback" registration rights with respect to the Registrable Shares to participate in certain securities offerings by the Company.

Termination. The Investment Agreement may be terminated by either the Company or the Investor under specified circumstances, including if (a) there is a Material Adverse Effect (as defined in the Investment Agreement) with respect to the . . .



Item 3.02. Unregistered Sales of Equity Securities.

The disclosure set forth above in Item 1.01 with respect to the Option Agreement is hereby incorporated by reference into this Item 3.02. The Company Common Stock to be issued pursuant to the Option Agreement will be issued in transactions exempt from registration under the Securities Act of 1933, as amended, in reliance on Section 4(2) thereof.



Item 8.01. Other Events.

On August 10, 2012, the Company announced that it entered into a strategic alliance with the Investor on the terms and conditions set forth in the Investment Agreement. A copy of the press release announcing the strategic alliance is attached as Exhibit 99.1 hereto and is incorporated herein by reference.




Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number   Description

4.1              Registration Rights (incorporated by reference to Exhibit C
                 to the Investment and Strategic Cooperation Agreement filed
                 as Exhibit 10.1 hereto)

10.1             Investment and Strategic Cooperation Agreement by and between
                 Janus Capital Group Inc. and The Dai-Ichi Life Insurance
                 Company, Limited, dated as of August 10, 2012.

10.2             Option Agreement, by and between Janus Capital Group Inc. and
                 The Dai-Ichi Life Insurance Company, Limited, dated as of
                 August 10, 2012.

99.1             Press Release, dated August 10, 2012.


  Add JNS to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for JNS - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.